Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Equinox and Morgan Stanley partner with Longchamp in the European regulated CTA sector

Monday, March 25, 2013
Opalesque Industry Update – Morgan Stanley and Equinox Fund Management LLC (“Equinox”), a U.S.-based multi-manager, have announced their partnership with Longchamp Asset Management, (“Longchamp”) a French asset management company, together “the parties”, in the European regulated CTA space. Through this partnership with Longchamp, Morgan Stanley and Equinox will drive the offering of Commodity Trading Advisor (CTA) strategies forward after successfully launching four CTA strategies on Morgan Stanley’s FundLogic Alternatives Platform in recent months. The four funds offer exposure to complementary strategies implemented by highly talented and renowned managed futures trading advisors including Winton Capital Management, Quantitative Investment Management, Mesirow Financial and Quest Partners.

Through this collaboration, the parties are leveraging their respective expertise by which Morgan Stanley provides its expertise in prime brokerage and futures clearing merchant as well as the fund infrastructure while Equinox contributes its strong CTA expertise and Longchamp their deep knowledge of the European investor base. As such, Longchamp will work jointly with Morgan Stanley to distribute the CTA offering throughout Europe.

“Our collaboration with Equinox and Longchamp and the launch of the first four strategies was an important milestone for our Funds business. It has provided us with the opportunity to expand our product range and offer investors access to this diversifying asset class”, commented Stephane Berthet, Head of FundLogic Alternatives UCITS Platform at Morgan Stanley. “CTAs are a key asset class in portfolio construction given their diversification benefits and potentially contrarian behavior in adverse market environments. We are looking forward to further expanding our capabilities through the partnership with Longchamp.”

David Armstrong, President and Founder of Longchamp commented: “We are thrilled to make concrete our long lasting ties with Morgan Stanley and Equinox through the creation of Longchamp. Equinox’s investment in Longchamp is a further evidence of their commitment to making the distribution of CTA strategies in a UCITS format a huge success.” He added: “We believe Morgan Stanley’s leadership and expertise will prove key factors in successfully making CTA strategies accessible in a UCITS fund format.”

Michel Serieyssol, Managing Director at Equinox and Member of the Advisory Board of Longchamp, added: “Our venture with Longchamp allows us to implement our longstanding aspiration to establish ourselves in Europe. Morgan Stanley’s financial engineering team has been successful in the design of a unique solution through which CTA managers are able to access both the U.S. and European regulated markets leveraging the same technology.”

FundLogic is the brand name for Morgan Stanley’s fund solutions platform launched in 2006. It offers both UCITS and non-UCITS funds. The platform delivers fund solutions to clients by combining the financial expertise, innovation and resources of Morgan Stanley, and offers a range of products including passive index funds, structured funds and the more recently launched third party manager- UCITS funds.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its